[Retracted] Network Pharmacology-Based Analysis on Lonicera japonica for Chronic Osteomyelitis Treatment

Table 1

The active ingredients with antiosteomyelitis from LJP.

Mol ID	Molecule name	OB (%)	DL	Structure
MOL003062	4,5′-Retro-beta,beta-carotene-3,3′-dione, 4′,5′-didehydro-	31.22	0.55
MOL003044	Chryseriol	35.85	0.27
MOL000006	Luteolin	36.16	0.25
MOL000358	Beta-sitosterol	36.91	0.75
MOL002773	Beta-carotene	37.18	0.58
MOL002914	Eriodyctiol (flavanone)	41.35	0.24
MOL000422	Kaempferol	41.88	0.24
MOL001494	Mandenol	42	0.19
MOL003124	Xylostosidine	43.17	0.64
MOL002707	Phytofluene	43.18	0.5
MOL003036	ZINC03978781	43.83	0.76
MOL000449	Stigmasterol	43.83	0.76
MOL001495	Ethyl linolenate	46.1	0.2
MOL003101	7-Epi-vogeloside	46.13	0.58
MOL000098	Quercetin	46.43	0.28
MOL003059	Kryptoxanthin	47.25	0.57
MOL003128	Dinethylsecologanoside	48.46	0.48
MOL003095	5-Hydroxy-7-methoxy-2-(3,4,5-trimethoxyphenyl)chromone	51.96	0.41
MOL003014	Secologanic dibutylacetal_qt	53.65	0.29
MOL003108	Caeruloside C	55.64	0.73
MOL003111	Centauroside_qt	55.79	0.5
MOL003117	Ioniceracetalides B_qt	61.19	0.19
MOL003006	(-)-(3R,8S,9R,9aS,10aS)-9-Ethenyl-8-(beta-D-glucopyranosyloxy)-2,3,9,9a,10,10a-hexahydro-5-oxo-5H,8H-pyrano[4,3-d]oxazolo[3,2-a]pyridine-3-carboxylic acid_qt	87.47	0.23